TYME TECHNOLOGIES INC (TYME) Stock News
NASDAQ:TYME - Nasdaq - US90238J1034 - Common Stock - Currency: USD
TYME Latest News, Press Relases and Analysis
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday and what's moving them!
Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.
Syros and Tyme Technologies Announce Stockholder Approval of Merger
-- Combined Company to Trade on Nasdaq Under Ticker “SYRS” ---- Syros Announces 1-for-10 Reverse Stock Split of Common Stock -- CAMBRIDGE, Mass. and...
Syros and Tyme Technologies Announce Stockholder Approval of Merger
Mentions: SYRS
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Investors can start off the day with a breakdown of the biggest pre-market stock movers for Tuesday and the news moving those shares!
TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and Tyme
BEDMINSTER, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (“Tyme” or the “Company”), today announced that independent...
SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Syros Pharmaceuticals,...
Mentions: SYRS
Shareholder Alert: Ademi LLP investigates whether TYME Technologies, Inc. has obtained a Fair Price in its transaction with Syros
/PRNewswire/ -- Ademi LLP is investigating TYME (NASDAQ:TYME) for possible breaches of fiduciary duty and other violations of law in its transaction with Syros....
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
Mentions: SYRS
TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results
-- $84.0 million in cash and marketable securities as of March 31, 2022 --...
TYME Technologies, Inc. Announces Exploration of Strategic Options
BEDMINSTER, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company...
TYME Technologies, Inc. Announces Changes to its Board of Directors
TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
-- Preclinical results from Georgetown University support that SM-88 is potentially a novel anti-cancer agent in drug resistant estrogen receptor positive...
TYME Technologies, Inc. Provides Business Update and Announces Third Fiscal Quarter 2022 Financial and Operating Results
